Monday, April 14, 2014

Merck Pipeline has 10 drugs currently under Review for Potential Approval, 12 in Phase III and 16 in Phase II

The List of the 10 drugs:
-
#1 Allergy, Grass Pollen
MK-7243 (US) 
 -
#2 Allergy, Ragweed
MK-3641 (US)
-
#3 Antifungal
NOXAFIL,
MK-5592 (IV)
-
#4 Fertility
corifollitropin alfa injection,
MK-8962 (US)
-
#5  Hepatitis C
vaniprevir
MK-7009 (Japan)
-
#6  HPV-related cancers
HPV vaccine (9 valent)
V503 (US)
-
#7 Insomnia
suvorexant,
MK-4305 (US)
-
#8  Neuromuscular Blockage Reversal
sugammadex,
MK-8616 (US)
-
#9  Platinum-Resistant Ovarian Cancer
vintafolide,
MK-8109 (EU)
 -
#10  Thrombosis
vorapaxar,
MK-5348 (US/EU)

For the full list of the drugs in Phase III and Phase II go to: Drug PipeLine for Merck

No comments:

Post a Comment